Evidence map›Paper›PMID 40296542›Full record

ArticleJournal of cosmetic dermatology2025

Subdermal Laser-Assisted Scar Subcision (SLASS) Combined With Fractional CO

Adrián Alegre-Sánchez, Ana Suárez-Valle, Diego Fernández-Nieto, Alejandro Lapeña, Elena Macías-Del Toro, Claudia Bernárdez

Abstract read
In one paragraph

Article in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adrián Alegre-SánchezDermatology Clinic AB Derma, Madrid, Spain.ORCID https://orcid.org/0000-0003-0451-6023
Ana Suárez-ValleDermatology Clinic AB Derma, Madrid, Spain.
Diego Fernández-NietoDermatology Clinic AB Derma, Madrid, Spain.ORCID https://orcid.org/0000-0003-4461-1770
Alejandro LapeñaDermatology Clinic AB Derma, Madrid, Spain.
Elena Macías-Del ToroDermatology Clinic AB Derma, Madrid, Spain.
Claudia BernárdezDermatology Clinic AB Derma, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRolling atrophic acne scars attach the deeper dermis to the muscular-fascial layer with a fibrous component. Subcision is the most commonly used treatment technique for rolling scars.

aimsOur objective is to describe the efficacy and safety profile of a new type of subcision: the "subdermal laser-assisted scar subcision" (SLASS), using a 1470-nm diode fiber laser in combination with ablative fractional CO PATIENTS/

methodsA retrospective study of the combination of subcision with subdermal laser and CO

resultsMean reduction of the ECCA grade scale before and after treatment was of 92.6 ± 34.3 points (p < 0.05). Considering SCAR-S scale, ranging from 0 to 5 (0 = clear; 5 = very severe), a mean improvement of 1.67 points was obtained (p < 0.05). Significant differences were found in both ECCA scale and SCAR-S scale before and after treatment. None of the patients had severe adverse effects after the procedure.

conclusionsSLASS subcision can be considered as a promising technique for rolling acne scars. It provides a thermo-mechanical subcision effect to the scarred area compared with traditional subcision techniques. CO

Indexed as

Acne VulgarisCicatrixLasers, GasLasers, SemiconductorLaser TherapyAdolescentAdultCombined Modality TherapyFemaleHumansMaleRetrospective StudiesTreatment OutcomeYoung Adultacne scarsCO2 laserendolaserendoliftrolling scarssubcision

Identifiers

PMID40296542
PMCPMC12038311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.